---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-25-003727"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T18:28:23.518520+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro amends bylaws to lower stockholder quorum to 35%, creates Series C Preferred Stock

## Summary
- Board reduced quorum for stockholder meetings from majority of outstanding shares to 35%.
- Filed Certificate of Designation for Series C Convertible Preferred Stock with Delaware.
- Series C issuance part of previously disclosed exchange and purchase agreement with a sophisticated investor.
- Exchange of 97.7511 shares of Series A for Series C; up to 500 additional Series C shares to be sold.

## SEC filing metadata
- accession: 0001214659-25-003727
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465925003727/0001214659-25-003727-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465925003727/p312508k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-25-003727
- JSON: https://secwatch.observer/filing/0001214659-25-003727.json
- Plain text: https://secwatch.observer/filing/0001214659-25-003727.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.